André Weinstock

Company: Alport syndrome Foundation Inc.

Job title: Director - Research

Seminars:

12:00 PM Panel Discussion: Defining Surrogate Endpoints for Rare Kidney Disease 12:00 pm

Analyzing lessons learned regarding surrogate endpoints for rare and genetic kidney diseases Examining the application of PLA IIR as a potential endpoint for Membranous Nephropathy Outlining the unique considerations relating to demonstrating efficacy in transplant patients with disease recurrenceRead more

day: Conference Day 1

11:00 AM Pioneering Predictive Biomarkers & Surrogate Endpoints in Rare & Genetic Kidney Disease for Streamlined Translational Development 11:00 am

Join this workshop to gain critical knowledge and practical strategies for leveraging predictive biomarkers and surrogate endpoints to significantly streamline the translational development pathway for therapies in rare and genetic kidney diseases, ultimately benefiting patients by accelerating the availability of new treatments. Defining appropriate early and reliable biomarkers to predict disease progression and response to…Read more

day: Pre-Conference Workshop Day